Jul 30, 2021

New research: How women’s hormone therapies could help reduce the risk of dementia

Senior woman at beach

A new study by the University of Arizona Health Sciences has found that women using hormone therapies were up to 58% less likely to develop neurodegenerative diseases, such as dementia.

The degree of risk varied depending on the type and application method of hormone therapy and how long the therapy was used.

“What is important about this study is that it advances the use of precision hormone therapies in the prevention of neurodegenerative disease, including Alzheimer’s,” said Roberta Diaz Brinton PhD, Director of the University of Arizona Center for Innovation in Brain Science and the senior author of the paper. 

Hormone therapy is used to treat the symptoms of menopause, which can include hot flashes, night sweats, insomnia, weight gain and depression. 

In the study, the researchers looked at the insurance claims of nearly 400,000 women aged 45 and older who were in menopause.

The researchers focused on the effects of hormone therapy medications on neurodegenerative diseases, and looked at the impacts of the type of hormone therapy, the route of administration (oral vs through the skin) and how long the therapy was taken.

Hormone therapies taken orally resulted in a reduced risk for combined neurodegenerative diseases.

Hormone therapies administered through the skin reduced the risk of developing dementia. 

The risk of developing neurodegenerative disease overall was reduced the most in patients 65 years or older.

Long-term therapy (longer than one year) had a greater protective effect on developing Alzheimer’s, Parkinson’s disease and dementia compared to short-term therapy (less than one year).

A press release from the university said the findings could lead to the development of medicines that could prevent neurodegenerative diseases.

“The key is that hormone therapy is not a treatment, but it’s keeping the brain and this whole system functioning, leading to prevention. It’s not reversing disease; it’s preventing disease by keeping the brain healthy.”

Given the global problems associated with ageing populations, neurodegenerative diseases associated with ageing are major public health issues.

Currently, there is no known cure for dementia, which affects nearly 500,000 people in Australia and 50 million worldwide.

Leave a Reply

Your email address will not be published. Required fields are marked *

  1. Any indication that they wouldn’t suffer a Stroke, cos I took HRT for 10years and had a stroke! But I don’t have dementia and I’m 82.

Banner Banner
Advertisement

Living Well with Dementia: Using the Montessori Approach in Community Based Programs

Omnicare Alliance is a community impact organisation with a focus on aged and disability support on the Mid North Coast, following the merger between HDRC Services, Meals on Wheels MNC, Hastings Home Modifications & Maintenance, Parklands Cottage and Hastings Headway. Omnicare’s organisational purpose is to engage, include, connect and support; with our core value being... Read More

Immediate coordinated action needed to save lives of people living with dementia

Dementia Australia today called for immediate action to prevent neglect or worse - premature death – and ensure appropriate support and care of people living with dementia in residential aged care homes during the COVID-19 pandemic. Dementia Australia CEO Maree McCabe said while a discussion about the current systemic breakdowns is both valid and necessary, our focus must be on the crisis at hand in Victoria. Read More

“Dementia is the only illness I know where people are told to go home and prepare to die via aged care rather than fight for their lives.”

There are more than 50 million people living with dementia around the world – and approximately 1 new diagnosis every 3.2 seconds. In Australia alone, there one more than 413, 000 people diagnosed with dementia. One notable person, is Kate Swaffer, the CEO and co-founder of Dementia Alliance International. Kate spoke at ITAC 2017 about... Read More
Banner Banner
Advertisement